These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 26830351

  • 1. Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis.
    Farahani M, Novitsky V, Wang R, Bussmann H, Moyo S, Musonda RM, Moeti T, Makhema JM, Essex M, Marlink R.
    AIDS Res Hum Retroviruses; 2016 Jun; 32(6):573-8. PubMed ID: 26830351
    [Abstract] [Full Text] [Related]

  • 2. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial.
    Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, Farahani M, Li Y, van Widenfelt E, Page JB, Bussmann H, Fawzi WW, Moyo S, Makhema J, Thior I, Essex M, Marlink R.
    JAMA; 2013 Nov 27; 310(20):2154-63. PubMed ID: 24281460
    [Abstract] [Full Text] [Related]

  • 3. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC.
    N Engl J Med; 2001 Mar 08; 344(10):720-5. PubMed ID: 11236775
    [Abstract] [Full Text] [Related]

  • 4. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM, Fischl MA, Stanley K, Collier AC, Spiegelman D.
    AIDS Res Hum Retroviruses; 2001 Aug 10; 17(12):1099-105. PubMed ID: 11522179
    [Abstract] [Full Text] [Related]

  • 5. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Möst J.
    Int Arch Allergy Immunol; 1998 Jul 10; 116(3):228-39. PubMed ID: 9693271
    [Abstract] [Full Text] [Related]

  • 6. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
    MacArthur RD, Perez G, Walmsley S, Baxter JD, Mullin CM, Neaton JD, Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) 042/045, Canadian HIV Trials Network (CTN) 102 Protocol Teams.
    HIV Clin Trials; 2005 Jul 10; 6(3):127-35. PubMed ID: 16192247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?
    Girard PM, Nelson M, Mohammed P, Hill A, van Delft Y, Moecklinghoff C.
    AIDS; 2013 Nov 13; 27(17):2759-63. PubMed ID: 23842127
    [Abstract] [Full Text] [Related]

  • 9. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.
    AIDS; 2006 May 12; 20(8):1117-23. PubMed ID: 16691062
    [Abstract] [Full Text] [Related]

  • 10. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A, Olmo M, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Domingo P, Oteo JA, Curto J, Vilallonga C, Masiá M, López-Aldeguer J, Iribarren JA, Podzamczer D, STOPAR study team.
    Antivir Ther; 2013 May 12; 18(1):125-30. PubMed ID: 22805174
    [Abstract] [Full Text] [Related]

  • 11. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
    Leeme TB, Mine M, Lechiile K, Mulenga F, Mosepele M, Mphoyakgosi T, Muthoga C, Ngidi J, Nkomo B, Ramaabya D, Tau M, Tenforde MW, Hayes R, Jarvis JN.
    HIV Med; 2021 Jan 12; 22(1):1-10. PubMed ID: 32876378
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.
    Martinez SS, Campa A, Bussmann H, Moyo S, Makhema J, Huffman FG, Williams OD, Essex M, Marlink R, Baum MK.
    Br J Nutr; 2016 Jun 12; 115(12):2114-21. PubMed ID: 27087233
    [Abstract] [Full Text] [Related]

  • 16. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 12; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M, Swiss HIV Cohort Study.
    Clin Infect Dis; 2005 Aug 01; 41(3):361-72. PubMed ID: 16007534
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.